Similar Articles
1751 Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing
1752 Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma
1753 Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma
1754 Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis
1755 Expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma
1756 Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma
1757 Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues
1758 Fumagillin treatment of hepatocellular carcinoma in rats: An in vivo study of antiangiogenesis
1759 Tumor vaccine against recurrence of hepatocellular carcinoma
1760 Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA